ArticleGlobalization and health2025
Strategic decoupling through legitimacy: the sustainability-innovation gap in the food processing sector and its health implications.
Article in Globalization and health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEnvironmental and public health impacts are critical in the food processing industry. To demonstrate responsiveness to stakeholder expectations, firms foreground sustainability reporting through frameworks such as Environmental, Social, and Governance (ESG) and Corporate Social Responsibility (CSR). Yet the sustainability rhetoric usually centers on visible, marketable, and peripheral dimensions, including packaging, energy use, and philanthropy. In contrast, domains within their core operations, including product composition, nutritional quality, and marketing ethics, receive limited attention. Subsequently, concerns over the commercial determinants of health rise, particularly for vulnerable populations.
methodsThe study follows an embedded mixed-methods design to examine whether sustainability disclosures align with firms' innovation strategies. Using 2023 data from 90 multinational or export-oriented food processing firms, hierarchical and multiple regression models assess the effects of ESG sub-dimensions and CSR scores on R&D expenditure, controlling for market capitalization (MC). To complement the quantitative analysis, the study includes a qualitative examination of selected firms, illustrating how sustainability-innovation gaps manifest in practice.
resultsFindings reveal no systematic alignment between sustainability and innovation strategies. The environmental dimension shows a marginally positive yet statistically insignificant relationship with R&D, while social, governance, and CSR metrics exhibit no meaningful association. MC remains the strongest predictor of R&D, highlighting that financial and organizational capacity drives innovation rather than sustainability commitment. Notably, CSR aligns more closely with environmental than social performance, indicating a selective legitimacy orientation. Firm-level evidence also reflects the patterns of symbolic compliance, illustrating how strong ESG scores can coexist with weak sustainability integration.
conclusionThe weak coupling between sustainability communication and innovation behavior exposes a structural gap between corporate legitimacy efforts and tangible outcomes for sustainable development. Firms that prioritize reputational visibility over substantive innovation reinforce health inequities and constrain systemic reform. To enhance environmental and public health outcomes, both corporate and regulatory strategies should move beyond symbolic compliance toward outcome-based accountability. Such a shift can better incentivize innovation that enhances nutritional quality, strengthens social equity, and protects environmental integrity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.